We were unable to get together for this year’s National IDeA Symposium of Biomedical Research Excellence. In response to requests from the community, we’re hosting a virtual meeting for investigators and program leaders supported by the Institutional Development Award (IDeA) program:
The objectives of the meeting are to:
* Introduce strategies and initiatives from NIH and NIGMS leaders in response to COVID-19
* Highlight scientific progress by IDeA investigators and trainees
* Answer questions from IDeA grantees
The Institutional Development Award (IDeA) is a congressionally mandated program that builds research capacity in states that historically have had low levels of National Institutes of Health (NIH) funding. It supports competitive basic, clinical, and translational research, faculty development, and infrastructure improvements. The program aims to strengthen an institution’s ability to support biomedical research, enhance the competitiveness of investigators in securing research funding, and enable clinical and translational research that addresses the needs of medically underserved communities.
IDeA-eligible states include: Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, Wyoming, and Puerto Rico
The IDeA program has five main components:
* Centers of Biomedical Research Excellence (COBRE)
* IDeA Networks of Biomedical Research Excellence (INBRE)
* IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)
* IDeA Co-funding
* STTR Regional Technology Transfer Accelerator Hubs for IDeA States